Of note, memory CD8+ T cells can be activated by cytokines under definite settings, which induce a specific NK-like killer phenotype, characterized by the acquisition of cytotoxicity towards tumor cells via NKG2D activation without requirement of TCR engagement [143,151]. The gene discussed is CD8A; the disease is neoplasm.